Emicizumab Has Strong Safety, Efficacy Record in Real-World Usage
The most common treatment-related adverse events were injection site reactions, the study found.
Source: ajmc.com
📰 Pract Thromb News
Pract Thromb News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pract Thromb. Real-time updates on events, politics, business and more.
Journey to Anticoagulant Access Following Payer Rejection of Apixaban
Formulary restrictions can create treatment barriers for patients with atrial fibrillation, including unnecessary delays in treatment and prescription abandonment, with vulnerable populations at greater risk.
Source: ajmc.com
Pleiotropic effects of ticagrelor
This study aimed to investigate if ticagrelor could change the expression of CYP4F2 and its encoded protein concentration.
Source: dovepress.com